Nuvation Bio Inc (NUVB) is now in the Undervalued zone, suggesting that its current forward PS ratio of 19.10 is considered Undervalued compared with the five-year average of -8.25. The fair price of Nuvation Bio Inc (NUVB) is between 10.11 to 16.64 according to relative valuation method. Compared to the current price of 5.91 USD , Nuvation Bio Inc By Undervalued By 41.53%.

Relative Value

Fair Zone

10.11-16.64

Current Price：5.91

41.53%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Nuvation Bio Inc (NUVB) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Nuvation Bio Inc (NUVB) has a current Price-to-Book (P/B) ratio of 9.02. Compared to its 3-year average P/B ratio of 1.86, the current P/B ratio is approximately 386.39% higher. Relative to its 5-year average P/B ratio of 2.18, the current P/B ratio is about 313.22% higher. Nuvation Bio Inc (NUVB) has a Forward Free Cash Flow (FCF) yield of approximately -6.47%. Compared to its 3-year average FCF yield of -16.86%, the current FCF yield is approximately -61.63% lower. Relative to its 5-year average FCF yield of -13.66%, the current FCF yield is about -52.65% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NUVB competitors is 109.78, providing a benchmark for relative valuation. Nuvation Bio Inc Corp (NUVB.N) exhibits a P/S ratio of 19.10, which is -82.6% above the industry average. Given its robust revenue growth of 1704.68%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NUVB increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NUVB in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NUVB currently overvalued or undervalued?

What is Nuvation Bio Inc (NUVB) fair value?

NUVB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Nuvation Bio Inc (NUVB) is between 10.11 to 16.64 according to relative valuation method.

How does NUVB's valuation metrics compare to the industry average?

The average P/S ratio for NUVB's competitors is 109.78, providing a benchmark for relative valuation. Nuvation Bio Inc Corp (NUVB) exhibits a P/S ratio of 19.10, which is -82.60% above the industry average. Given its robust revenue growth of 1704.68%, this premium appears sustainable.

What is the current P/B ratio for Nuvation Bio Inc (NUVB) as of Mar 02 2026?

As of Mar 02 2026, Nuvation Bio Inc (NUVB) has a P/B ratio of 9.02. This indicates that the market values NUVB at 9.02 times its book value.

What is the current FCF Yield for Nuvation Bio Inc (NUVB) as of Mar 02 2026?

As of Mar 02 2026, Nuvation Bio Inc (NUVB) has a FCF Yield of -6.47%. This means that for every dollar of Nuvation Bio Inc's market capitalization, the company generates -6.47 cents in free cash flow.

What is the current Forward P/E ratio for Nuvation Bio Inc (NUVB) as of Mar 02 2026?

As of Mar 02 2026, Nuvation Bio Inc (NUVB) has a Forward P/E ratio of -15.02. This means the market is willing to pay $-15.02 for every dollar of Nuvation Bio Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Nuvation Bio Inc (NUVB) as of Mar 02 2026?

As of Mar 02 2026, Nuvation Bio Inc (NUVB) has a Forward P/S ratio of 19.10. This means the market is valuing NUVB at $19.10 for every dollar of expected revenue over the next 12 months.

NUVB Valuation